Soleus Capital Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-224,600
| Closed | -$13M | – | 97 |
|
|
2024
Q3 | $13M | Buy |
224,600
+3,000
| +1% | +$174K | 1.01% | 33 |
|
|
2024
Q2 | $10.1M | Sell |
221,600
-52,000
| -19% | -$2.38M | 0.89% | 37 |
|
|
2024
Q1 | $18.1M | Buy |
+273,600
| New | +$18.1M | 1.34% | 20 |
|
|
2023
Q4 | – | Sell |
-12,700
| Closed | -$405K | – | 92 |
|
|
2023
Q3 | $405K | Sell |
12,700
-58,100
| -82% | -$1.85M | 0.04% | 90 |
|
|
2023
Q2 | $2.84M | Sell |
70,800
-51,516
| -42% | -$2.07M | 0.32% | 63 |
|
|
2023
Q1 | $5.22M | Sell |
122,316
-110,800
| -48% | -$4.73M | 0.54% | 49 |
|
|
2022
Q4 | $11.2M | Buy |
233,116
+87,116
| +60% | +$4.18M | 1.61% | 24 |
|
|
2022
Q3 | $5.49M | Buy |
+146,000
| New | +$5.49M | 0.75% | 39 |
|